日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Radio-sensitizing effect of MEK inhibition in glioblastoma in vitro and in vivo

MEK抑制剂在体外和体内对胶质母细胞瘤的放射增敏作用

Houweling, M; Abdul, U K; Brahm, C; Lagerweij, T; Heukelom, S; Koken, P W; Honeywell, R; Wedekind, L E; Peters, G J; Verheul, H; Sminia, P; Noske, D; Wurdinger, T; Westerman, B A

Sorafenib administered using a high-dose, pulsatile regimen in patients with advanced solid malignancies: a phase I exposure escalation study

索拉非尼高剂量脉冲式给药方案治疗晚期实体恶性肿瘤患者:一项 I 期暴露量递增研究

Mammatas, L H; Zandvliet, A S; Rovithi, M; Honeywell, R J; Swart, E L; Peters, G J; Menke-van der Houven van Oordt, C W; Verheul, H M W

Randomized phase 2 study of gemcitabine and cisplatin with or without vitamin supplementation in patients with advanced esophagogastric cancer

一项随机II期研究,比较吉西他滨联合顺铂治疗晚期食管胃癌患者,并评估补充维生素的疗效。

van Zweeden, A A; van Groeningen, C J; Honeywell, R J; Giovannetti, E; Ruijter, R; Smorenburg, C H; Giaccone, G; Verheul, H M W; Peters, G J; van der Vliet, Hans J

Role of proton-coupled folate transporter in pemetrexed resistance of mesothelioma: clinical evidence and new pharmacological tools

质子偶联叶酸转运蛋白在间皮瘤培美曲塞耐药中的作用:临床证据和新的药理学工具

Giovannetti, E; Zucali, P A; Assaraf, Y G; Funel, N; Gemelli, M; Stark, M; Thunnissen, E; Hou, Z; Muller, I B; Struys, E A; Perrino, M; Jansen, G; Matherly, L H; Peters, G J

Non-canonical kinase signaling by the death ligand TRAIL in cancer cells: discord in the death receptor family

癌细胞中死亡配体TRAIL的非经典激酶信号传导:死亡受体家族的分歧

Azijli, K; Weyhenmeyer, B; Peters, G J; de Jong, S; Kruyt, F A E

Combined assessment of EGFR pathway-related molecular markers and prognosis of NSCLC patients

EGFR通路相关分子标志物与非小细胞肺癌患者预后的联合评估

Galleges Ruiz, M I; Floor, K; Steinberg, S M; Grünberg, K; Thunnissen, F B J M; Belien, J A M; Meijer, G A; Peters, G J; Smit, E F; Rodriguez, J A; Giaccone, G

Role of platelet-derived endothelial cell growth factor/thymidine phosphorylase in fluoropyrimidine sensitivity.

血小板衍生内皮细胞生长因子/胸苷磷酸化酶在氟尿嘧啶敏感性中的作用

de Bruin M, van Capel T, Van der Born K, Kruyt F A, Fukushima M, Hoekman K, Pinedo H M, Peters G J

Mechanisms of synergism between cisplatin and gemcitabine in ovarian and non-small-cell lung cancer cell lines

顺铂和吉西他滨在卵巢癌和非小细胞肺癌细胞系中的协同作用机制

van Moorsel, C J; Pinedo, H M; Veerman, G; Bergman, A M; Kuiper, C M; Vermorken, J B; van der Vijgh, W J; Peters, G J

5-ethyl-2'-deoxyuridine, a modulator of both antitumour action and pharmacokinetics of 5-fluorouracil

5-乙基-2'-脱氧尿苷,一种调节5-氟尿嘧啶抗肿瘤作用和药代动力学的药物。

Kralovánszky, J; Katona, C; Jeney, A; Pandi, E; Noordhuis, P; Erdélyi-Tóth, V; Otvös, L; Kovács, P; Van der Wilt, C L; Peters, G J

5-fluorouracil/leucovorin-induced inhibition of thymidylate synthase in normal tissues of mouse and man

5-氟尿嘧啶/亚叶酸钙诱导小鼠和人类正常组织中胸苷酸合成酶的抑制

van der Wilt, C L; van Groeningen, C J; Pinedo, H M; Smid, K; Hoekman, K; Meijer, S; Peters, G J